medigraphic.com
ISSN 1028-4796 (Print)

2014, Number 2

<< Back Next >>

Rev Cubana Plant Med 2014; 19 (2)

Evaluation of the antimicrobial and modulating activity of hexane extract from Costus cf. ArabicusL.

Sobral SCE, Figueiredo LN, Vieira BDI, Batista ALB, Lima SLAK, Ferreira MEF, Sabino AR, de Alencar FJV, Bezerra CFA, Relison TS, Martins CJG, Melo CHD

Language: Portugués
References: 34
Page: 151-159
PDF size: 118.70 Kb.


ABSTRACT

Introduction: Pseudomonas aeruginosa is known to cause acute infection due to the production of toxins. Some specimens of Staphylococcus are often recognized as the etiologic agents of opportunistic infections in many animals and humans.
Escherichia coli is a leading cause of human infectious diseases. The genus Candida produces several virulence factors. Infections are probably initiated by changes in host defenses.
Objective: evaluate the antimicrobial effect of hexane extract of Costus cf. and themodulation of Costus cf. Arabicus. L. antibiotic activity.
Methods: botanical material from Costus cf. arabicus L. was collected at Crato, Ceará, Brazil. For the preparation of extracts fresh leaves and stems were collected, separately immersed in hexane for 72 hours, and thereafter filtered and concentrated in a rotary vacuum condenser. Tests of antimicrobial activity (MIC) and antimicrobial activity modulation were conducted with multiresistant strain patterns of bacteria and fungi.
Results: the extract showed antibacterial and antifungal activity against some of the strains tested when combined with some antibiotics.
Conclusions: therefore, it is suggested that the extract of Costus cf. be used as a source of natural products for antimicrobial therapy and to combat bacterial and fungal multidrug resistance.


REFERENCES

  1. Murray PR. Laboratory Procedures for Epidemiologic Analysis. In: Manual of Clinical Microbiology. 6. ed., Washington: ASM Press; 1995.

  2. Palleroni NJ. Pseudomonas, classification: a new case history in the taxonomy of gram-negative bacteria. Antonie van Leeuwenhoek, 1993; 64(3-4):231-51.

  3. Nostro A, Blanco AR, Cannatelli MA, Enea V, Flamini G, Morelli I. Susceptibility of methicillin-resistant staphylococci to oregano essential oil, carvacrol and thymol. FEMS Microbiology Letter. 2004;230(2):191-5.

  4. Coutinho HDM, Costa JGM, Siqueira Jr JP, Lima EO. Effect of Momordica charantia L. in the resistance to aminoglycosides in ethicilin-resistant Staphylococcus aureus. Comp Immunol Microbiol Infect Dis. 2009; 33(6):467-71.

  5. Verhoef J, Beaujean D,Blok H, Baars A, Meyler, A, Werken VDC. A Ducht approach to methicillin-resistant Staphylococcus aureus. European Journal of Clinical Microbiol & Infectious Diseases. 1999;18(7):461-6.

  6. Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infection and Immunity. 1977;18(3):775-9.

  7. Konowalchuk J, Dickie NS, Stavric S, Speirs JI. Properties of an Escherichia coli cytotoxin. Infection and Immunity.1978;20(2):575-7.

  8. Scotland SM, Day NP, Willshaw GA, Rowe B. Cytotoxic enteropathogenic Escherichia coli. Lancet. 1980;1(8159):90.

  9. Hughes C, Muller D, Hacher J, Goebel W. Genetics and pathogenic role of Escherichia coli haemolysin. Toxicon. 1982;20(1):247-52. Revista Cubana de Plantas Medicinales 2014;19(2):151-159 http://scielo.sld.cu 158

  10. Sidrim JJC, Moreira JLB. Fundamentos Clínicos e Laboratoriais da Micologia Médica. Rio de Janeiro: Guanabara Koogan; 1999.

  11. Georgopapadakou NH. Infectious disease 2001: drug resistance, new drugs. Drug Resistance Updates. 2005;5(5):181-91.

  12. Dancer SJ. The problem with cephalosporins. The Journal of Antimicrobial Chemotherapy. 2001;48(4):463-78.

  13. Coutinho HDM, Cordeiro LN, Bringel KP. Antibiotic resistance of pathogenic bacteria isolated from the population of Juazeiro do Norte - Ceará. Revista Brasileira de Ciências da Saúde. 2005;9(1):127-38.

  14. Daferera DJ, Ziogas BN, Polissiou MG. The effectiveness of plant essential oils on the growth of Botrytis cinerea, Fusarium sp. and Clavibacte michiganenesis subsp. michiganenesis. Crop Protection. 2003;22(1):39-4.

  15. Araujo FP, Oliveira PE. Biologia floral de Costus spiralis (Jacq.) Roscoe (Costaceae) e mecanismos para evitar a autopolinização. Revista Brasileira de Botânica. 2007;30(1):61-70.

  16. Maas PJM. Costoidae (Zingiberaceae). Flora Neotropica, Monograph nº 8. New York: Hafner; 1972

  17. Stevenson DWM, Stevenson JW. Costaceae (Costus Family). In Flowering Plants of The Neotropics. Princeton: Princ Univer Press; 2004.

  18. Albuquerque JM. Plantas Medicinais de Uso Popular. Brasília:ABEAS; 1989.

  19. Van den Berg ME. Plantas Medicinais na Amazônia- Contribuição ao seu conhecimento sistemático. Belém: Museu Paranaense Emílio Goeldi; 1993.

  20. Corrêa AD, Siqueira-Batista R, Quintas LE.Plantas Medicinais do Cultivo à terapêutica. Petrópolis: Ed. Vozes 1998.

  21. Corrêa MP. Dicionário das Plantas Úteis do Brasil e das Exóticas Cultivadas. Rio de Janeiro: Ministério da Agricultura IBDF;1984

  22. Vieira LS, Albuquerque JM. Fitoterapia Tropical - Manual de Plantas Medicinais. Belém: FCAP - Serviço e Documentação e Informação; 1998.

  23. Mors WB, Rizzini CT, Pereira NA. Medicinal Plants of Brazil.Michigan: Reference Publications, Incorporated Algonac;2000.

  24. Boorhem RL. Segredos e Virtudes das Plantas Medicinais. Rio de Janeiro: Reader's Digest Brasil Ltda.;1999.

  25. Javadpour MM, Juban MM, Lo WC, Bishop SM, Alberty JB, Cowell SM. De novo antimicrobial peptides with low mammalian cell toxicity. Journal of Medicinal Chemistry. 1996; 39(16):3107-13.

  26. Saúde-Guimarães DA, Faria AR. Natural compounds with anti-Trypanossoma cruzi activity. Revista Brasileira de Farmacognosia. 2007;17(3):455-65. Revista Cubana de Plantas Medicinales 2014;19(2):151-159 http://scielo.sld.cu 159

  27. Barbosa-filho JM, Nascimento-Júnior FA, Tomaz ACA, Athayde-Filho PF, Silva MS, Cunha EVL. Natural products with antileprotic activity. Revista Brasileira de Farmacognosia. 2007;17(1):141-8.

  28. Biavatti M, Marensi V, Leite SN, Reis A. Ethnopharmacognostic survey on botanical compendia for potential cosmeceutic species from Atlantic Forest. Revista Brasileira de Farmacognosia. 2007;17(4):640-53.

  29. Oliveira FQ, Gobira B, Guimarães C, Batista J, Barreto M, Souza M. Plants species indicated in odontology. Revista Brasileira de Farmacognosia. 2007;17(3):466-76.

  30. Barbosa Filho JM, Alencar AA, Nunes XP, Tomaz ACA, Sena-Filho JG, Athayde- Filho PF. Sources of alpha-,beta-, gamma-, delta- and epsilon-carotenes: A twentieth century review. Revista Brasileira de Farmacognosia. 2008;18(1):135-54.

  31. Coutinho HDM, Costa JGM, Lima EO, Falcão-Silva VS, Siqueira JR JP. Enhancement of the antibiotic activity against a multiresistant Escherichia coli by Mentha arvensis L. and chlorpromazine. Chemotherapy. 2008;54(4):328-30.

  32. Matias EFF, Alves EF, Santos BS, Souza CES, Ferreira JVA, Lavor AKLS, Figueredo FG, Lima LF, Santos FAV, Peixoto FSN, Colares AV, Boligon AA, Saraiva RA, Athayde ML, Rocha JBT, Menezes IRA, Coutinho HDM, Costa JGM. Evidence- Based Complementary and Alternative Medicine. 2013;2013(1):1-7.

  33. Wendakoon C, Sakaguchi M. Inhibition of amino acid decarboxylase activity of Enterobacter aerogenes by active components in spices. Journal of Food Protection. 1995;58(3):280-3.

  34. Coutinho HDM, Costa JGM, Siqueira Jr JP, Lima EO. In vitro anti-staphylococcal activity of Hyptis martiusii Benth against methicillin-resistant Staphylococcus aureus-MRSA strains. Revista Brasileira de Farmacognosia. 2008;18(suppl.):670-5.




2020     |     www.medigraphic.com